Position in VSTM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$181,785
+$111,168 QoQ
Shares Held
47,588
+257.2% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 158 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VSTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Creative Planning holds $457,365,908 across 219 Biotechnology names. VSTM ranks #174 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
127,672 | $63,418,511 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,949 | $23,039,178 | |
| 3 | EXEL |
Exelixis, Inc.
|
270,292 | $14,706,586 | |
| 4 | INCY |
Incyte Corp
|
110,664 | $12,544,870 | |
| 5 | CYTK |
Cytokinetics Inc
|
141,939 | $12,091,783 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
64,120 | $12,008,393 | |
| 7 | ARGX |
Argenx SE
|
12,744 | $11,823,500 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
153,161 | $8,763,872 |
All Filings in VSTM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $181,785 | 47,588 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $70,617 | 13,324 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $115,962 | 15,021 | Shares | Sole | 2026-02-17 | |
| 2021-03-31 | $175,486 | 71,047 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $53,350 | 25,047 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $128,316 | 106,047 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $190,140 | 110,547 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $323,524 | 122,547 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||